2 studies found for:    16740761 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer
Conditions: Lung Cancer;   Non Small Cell Lung Cancer
Interventions: Drug: apricoxib;   Drug: Placebo
2 Completed Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: celecoxib;   Drug: erlotinib hydrochloride

Indicates status has not been verified in more than two years